NRG-GU002 for Prostate Cancer - Clinical Trial
What is the Purpose of this Study?
Who Can Participate in the Study?
Adult men who have prostate cancer and the prostate has been surgically removed:
- are 18 years or older
What is Involved?
If you agree to be in this study you will:
- Be randomly assigned (put into one of two groups by chance like a flip of a coin) and receive either:
Group 1 - continue to receive hormone suppression therapy and will get the usual radiation therapy used for prostate cancer
Group 2 - continue to receive hormone suppression therapy and get the usual radiation therapy used for prostate cancer followed by 6 doses of the chemotherapy drug docetaxel.
- Receive hormone suppression therapy for a total of 6 months
- See your doctors every 3 months for 2 years, then every 6 months for 3 years, and then yearly.